AIMBE Fellows represent the top 2% of medical and biological engineers. They include the most accomplished medical and biological engineers in academia, industry, education, clinical practice, and government. Congratulations to Dr. Rob Mitra for being inducted on March 31 in Arlington, Va. along with 169 other new fellows from across the United States.
Congratulations to Dr. Brett Maricque for receiving the 2025 Dean’s Impact Award.
Seven faculty members at Washington University in St. Louis are among the 471 new fellows selected by the American Association for the Advancement of Science (AAAS), one of the most distinct honors in the scientific community. Congratulations to Dr. Tim Schedl on his election to AAAS.
Congratulations to Dr. Guoyan Zhao and co-investigator Dr. Hiroko Yano for being selected for the Hope Center Pilot Grant! The project “Identification and validation of drug candidates for repurposing in Huntington disease” will be funded in full $100,000 for the award period of January 1, 2025 – December 31, 2026!
Emma Casey, a second year PhD student in the Jin lab has been awarded a highly competitive NINDS Diversity Supplement to work on characterizing and assessing the impact of mitochondrial DNA variations in congenital hydrocephalus. Emma is the first trainee from the Department of Genetics to receive the significant 3-year NIH grant award totaling $225K. Congratulations!
Washington University School of Medicine in St. Louis has received two large grants renewing funding for the Human Pangenome Reference Sequencing Project. This ambitious program began in 2019 with the goal of increasing the diversity of human genome sequences that are pooled into the widely used reference genome. A thorough representation of human genetic diversity can help researchers discover how genetic variation contributes to disease and perhaps offer new routes to innovative treatments.
Yung-Chun (David) Wang, PhD, an instructor in the Jin lab was recently awarded the Center of Regenerative Medicine’s hCTO microgrant. This microgrant will support his research into congenital hydrocephalus (CH), a developmental brain disorder characterized by abnormal cerebrospinal fluid accumulation.
Researchers at WashU Medicine have identified a possible way to make glioblastoma cells vulnerable to different types of immunotherapy. The strategy, which they demonstrated in cells in the lab, forces brain cancer cells to display targets for the immune system to attack.
A cross-disciplinary team of researchers and physicians from Washington University School of Medicine in St. Louis and colleagues from around the world has solved the mystery of a child with a rare genetic illness that did not fit any known disease. The team found a link between the child’s neurological symptoms and a genetic change that affects how proteins are properly folded within cells, providing the parents with a molecular diagnosis and identifying an entirely new type of genetic disorder.
Dr. Sheng Chih (Peter) Jin, has received a $3.2 million grant from the National Institutes of Health (NIH) to study the genetic and molecular underpinnings of congenital hydrocephalus.